Janelle Barowski, MSN RN

Sodium-glucose cotransporter-2 inhibitor use prior to the onset of COVID-19 infection was associated with the lowest risk for adverse outcomes in patients with diabetes.

Researchers evaluated the safety and efficacy of ensitrelvir for the treatment of mild to moderate COVID-19 infection during the Omicron wave.

Researchers evaluated the short-term safety profile of a second booster dose of a COVID-19 mRNA vaccine.

Researchers compared the presence of symptoms 2 years after acute COVID-19 infection between hospitalized and nonhospitalized patients.

Researchers evaluated the effectiveness of bivalent mRNA COVID-19 vaccination among adults who previously received at least 2 monovalent vaccine doses.